World’s Smallest Transcutaneous Bone Conduction Hearing Implant

Image credit: Sharon Waldron via Unsplash

The US Food and Drug Administration (FDA) has given the regulatory green light to Oticon Medical’s first active transcutaneous bone conduction hearing system.

The Sentio System is comprised of an implant placed under the skin together with an external sound processor, and is designed for candidates aged over 12 years who have conductive hearing loss, mixed hearing loss or single-sided deafness.

Touted by Oticon as the world’s smallest transcutaneous system currently on the market, the implant has been developed to avoid additional surgeries by supporting a patient’s progressive hearing loss over time.

“… Oticon Medical now offers a complete portfolio of bone-anchored hearing systems [which] meets the needs of patients and customers, and fits diverse clinical settings and global reimbursement schemes for the treatment,” said Oticon President & General Manager, René Govaerts in a statement.

“We strongly believe that offering a broad portfolio is the path to achieving our mission to “Help more people” and give more potential users the quality of life improvements these systems offer.”

Check out the full press release for more details.